Genetic variants linked to type 2 diabetes in <scp><i>CDKN1B</i></scp> and <scp><i>TCF7L2</i></scp> influence survival outcomes in metastatic colorectal cancer
Raffaella Ruggiero(Regione Campania), Giovanni Savarese(Regione Campania), Amalia Luce(University of Campania "Luigi Vanvitelli"), Monica Ianniello(Regione Campania), Silvia Zappavigna(University of Campania "Luigi Vanvitelli"), Madhura S. Tathode(University of Campania "Luigi Vanvitelli"), Massimiliano Berretta(University of Messina), Alessandro Ottaiano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Michele Caraglia(University of Campania "Luigi Vanvitelli"), Nadia Petrillo(Regione Campania), Roberto Sirica(Regione Campania), Annabella Di Mauro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 1
Related Papers
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
|Endocrine Related Cancer|2006|131
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
|PLoS ONE|2014|115
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
|Cell Death and Disease|2013|57
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
|Scientific Reports|2017|49
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma
|Molecular Therapy — Nucleic Acids|2019|41